| Tag | Content |
|---|
EnhancerAtlas ID | HS187-10082 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr17:10074090-10076070 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr17:10075767-10075785 | GGAAAGAAGAAAGGAAAA | + | 6.33 | | IRF1 | MA0050.2 | chr17:10075854-10075875 | AAAAAGAAACAGAAAGGGAGA | - | 6.66 | | NFYA | MA0060.3 | chr17:10075050-10075061 | TCTGATTGGTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09322 | chr17:10073655-10077845 | CD14 | | SE_54240 | chr17:10074198-10076460 | Spleen | | SE_66338 | chr17:10074380-10075780 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 10075017 | 10075299 | | chr17 | 10075775 | 10076068 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I010170 | chr17 | 10074055 | 10076369 |
|
Enhancer Sequence | TCTTGTTAAT CTGCTGAAAG GTTCCAATGA GAAAGAAAGT GGCCTTTTAA ACTTACATCT 60
TCTGCCCAGC AGCTCTGTCA CCTCGGAGGT GGTCTCTGAG CTTAGAAGTA TCCCTCTGCC 120
ACACATAAAT ACCATCACAG ATCCCTGAAC AACTCAAAGG CCAGCTGGCA CTTTCTGTGG 180
CTGAGCCAGC GAACCACTGG GATCAATTGT CTTCTAAGCT CAGCAATTTG CCTAAGTCCC 240
AGCCAAGGGC AAAAGTCCTC CTAACTCCCA GGCACCATTT CTCTCTCTGT AGCTTCACTT 300
GAGCCGCAAA GAATCCAGGA TCCCTCAAGC TCTGAGTTCC ATTCATGGAA AATCCTAAAA 360
CTTCCTTCAT CCCTTCAGTC AGAATCTTTT CCTCTTTTGG TTTGGAAGAA ACCCAGAGGT 420
GTTAAAACTG AACATCTTGA CCGAATTTCC TCCGGGCAAG CTTTCCCCAA GCTCGCTTAC 480
TCCAACACAC CAGCCCCTCC TGCCAGACCC AGTCAGAGCC AGACTTTTGA GTAACTTGGT 540
CCAAGCAGGG CTCTGACAGC GAACCCAGAA CCCCATTCAC AGCTGGCTCC CTGCCTGTCA 600
CCAAGAATAG CTCCTTAAAT CAGGTCTTCG GGTAACAAAT GAGGAACACA TCAATTTAGC 660
AGGAAATCGG CTTCCCTTGA AGCGTCTCTG AAGTTTGTTG AGACAAAAGG AATCTACAGT 720
GCTTGAGTAA TAGGAAAGAC CACCTGCAAC TTTTACAGAA CTTCTTTTGG ACTTGAAAAT 780
TCTAAGACGC TAGGGGGAAG AAATCTCGAA AATGAACAAG ATCCAAATGC ATAAGGATTC 840
ATTTCCCATC TCCCTAAATA ATCACAGCCA CATGCTTCTT ATCTGCCATA AAAACCAGGC 900
AGTCCGTGTA AGGGACGGGT GAAGCAGTGA AGAACGCTGG TCCTAAGCAG TGTTGAAACC 960
TCTGATTGGT TGTGTGTCCT GAGCAAATTC TTTGACCTCT CTGAGCCTTT ATCTGAGAAA 1020
TGGAATCCAC CTCGCCAGGC TGTTGATAAG ATTACATGAG AAATCCTGCA TGAAAGCCCT 1080
CTGTAACCGC TATAGGACTA AACAAGTGAC GTTTCAACAC ACACAGGAAA TGCCACTTAA 1140
GTTCAGAACT CTCTGAGGGG CACCAGGAGC AAGCACAAAA ATAAAAGACT GTCATCACTT 1200
TTGTCTTCAA GAAGCTTCAA GTTCAGCTGG GAAAACAGCA CACACAGGAC AGCGGATGAT 1260
CTAGCATTCG CAAAAGCAAC ATACTAAGAA AAGCATACAC CTCCATCTGC TGCTTTCCCC 1320
TAAGTGTCCC TCGGGTCTGC TTGTTTGGAT TCTAATATCT GCCTAACTAC CCATCAATCT 1380
GGCTACTTCC TGGACTGCAA AAGACCTCAA AGCTATGTGT AAAAGAAGTC TCTAAATCTA 1440
AGCCAGATAG GATGGCCTGC CATGGCAGCC CTCATTCCAC TCCTCAGGTC CAGTCCTGGT 1500
TGACTTCACC TCATCACCCA CCAGCCAGTG CAGCTAACCT CCTTCCTCTG CCGCATGTCC 1560
GGCCCTGCCC AAGGATTCCC CAGGGGGCAG CCAATCATCT TGTTCACCTC CAGCACAGCA 1620
CTGTGCATAA CACTCTGTAT TGCTCTCAAC TTTGCCCCCA GGCCAGCTGA AAGCAGAGGA 1680
AAGAAGAAAG GAAAACAGAA TTCAAATGGA GCAATTAGCA AAAGGAGAAA TGAGGAAGCA 1740
GATTAAAAAA AAAGAAGAAG AAAAAAAAAG AAACAGAAAG GGAGACAATC AAAGAAAAAA 1800
TGAGGAACAT ACAGAACTAT CACTTGACAT CTGACTTTAT AGCTTAGGAA GGGCTTAACC 1860
TCACATTCTG TGGCTTGCGC CTCTTACAAC ATTCTGCAGG GCTGAGTAAG CAAGGCAGGG 1920
AATTTTACAC CCATTTAGGA AATGAGCAAA CTAAGGCTTG ACAGACTTTA ATGAAGCGCT 1980
|
